BEVERLY, Mass. Nov. 18, 2024 Quanta Dialysis Technologies, a leader in transforming kidney care through its award-winning Quanta™ Dialysis System, has successfully closed its oversubscribed Series E Preferred Stock financing round, raising more than $60 million of additional capital. Led by Novo Holdings, Glenview Capital and b2venture, with broad participation by existing shareholders, this latest funding round underscores strong […]
BEVERLY, Mass. Nov. 4, 2024 Award-winning medical technology innovator, Quanta Dialysis Technologies®, has confirmed the US Food and Drug Administration (FDA) has given 510(k) clearance for the use of its Quanta Dialysis System in the home setting. With this clearance, Quanta becomes the only company to offer a high dialysate flow (500 mL/min) system across […]
Trial results reinforce use clinical benefits of home hemodialysis (HHD) BEVERLY, Massachusetts – October 30, 2023 – Quanta Dialysis Technologies, a medical technology company committed to making kidney care more accessible with its Quanta™ Dialysis System, today announced the presentation of real-world evidence from its Home Run™ study at the American Society of Nephrology (ASN) […]
New expanded indication will increase home hemodialysis device options available to patients with end-stage kidney disease BEVERLY, Massachusetts – September 19, 2023 – Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) […]
Experienced medical device executive will lead global manufacturing, supply chain, logistics, product quality and demand planning teams BEVERLY, MASSACHUSETTS – August 8, 2023 – Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced the appointment of Suresh Persaud as its Senior Director of Global Manufacturing and Operations, effective […]
Multi-center trial assesses efficacy and safety of the Quanta Dialysis System BEVERLY, Massachusetts – August 17, 2023 – Quanta Dialysis Technologies® today announced that it has completed enrollment of its Home Run study for at-home hemodialysis. The Home Run study is a prospective, multi-center, open-label trial to assess the efficacy and safety of the Quanta […]
Quanta Dialysis System becomes first-in-class to perform three standard-of-care dialysis modalities in one device BEVERLY, Mass., Aug. 3, 2023 /PRNewswire/ — Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication of the Quanta […]
Unanimous Endorsement of MannKind Executive Follows Extensive Search BEVERLY, MASSACHUSETTS – September 28, 2022 – Quanta Dialysis Technologies® Ltd (“Quanta” or the “Company”), a medical technology company committed to making kidney care more accessible with its Quanta™ Dialysis System, today announced that its Board of Directors has unanimously elected Alejandro Galindo, M.B.A., M.S. as the […]
13 JULY 2022: The team behind a revolutionary portable dialysis machine that enables patients to treat themselves at home and relieves pressure on over-stretched hospitals, has won the UK’s leading engineering innovation award for 2022. The Royal Academy of Engineering has today announced Quanta Dialysis Technologies as the recipient of the 2022 MacRobert Award, the […]
Hooman Hakami, former Medtronic executive, named Interim CEO BEVERLY, Massachusetts – June 30, 2022 – Quanta Dialysis Technologies Inc (“Quanta or “The Company”), a medical technology company committed to making kidney care more accessible with its SC+ hemodialysis system, announced today that CEO John E. Milad will leave the company effective July 15, 2022. The […]